OPCH Quote, Financials, Valuation and Earnings

Amedisys has a net margin of 4.21% compared to Option Care Health's net margin of 2.88%. Option Care Health's return on equity of 14.65% beat Amedisys's return on equity of 7.23%.

Option Care Health has a consensus price target of --, signalling upside risk potential of 31.78%. On the other hand Amedisys has an analysts' consensus of $96.33 which suggests that it could grow by 7.09%. Given that Option Care Health has higher upside potential than Amedisys, analysts believe Option Care Health is more attractive than Amedisys.

Option Care Health has a beta of 1.332, which suggesting that the stock is 33.16% more volatile than S&P 500. In comparison Amedisys has a beta of 0.726, suggesting its less volatile than the S&P 500 by 27.385%.

Option Care Health has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Amedisys offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Option Care Health pays -- of its earnings as a dividend. Amedisys pays out -- of its earnings as a dividend.

Option Care Health quarterly revenues are $1.3B, which are larger than Amedisys quarterly revenues of $587.7M. Option Care Health's net income of $53.9M is higher than Amedisys's net income of $16.9M. Notably, Option Care Health's price-to-earnings ratio is 19.20x while Amedisys's PE ratio is 35.70x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Option Care Health is 0.84x versus 1.28x for Amedisys. Usually stocks with elevated PS ratios are considered overvalued.

Humana has a net margin of 4.21% compared to Option Care Health's net margin of 1.63%. Option Care Health's return on equity of 14.65% beat Humana's return on equity of 8.1%.

Option Care Health has a consensus price target of --, signalling upside risk potential of 31.78%. On the other hand Humana has an analysts' consensus of $287.90 which suggests that it could grow by 12.62%. Given that Option Care Health has higher upside potential than Humana, analysts believe Option Care Health is more attractive than Humana.

Option Care Health has a beta of 1.332, which suggesting that the stock is 33.16% more volatile than S&P 500. In comparison Humana has a beta of 0.532, suggesting its less volatile than the S&P 500 by 46.758%.

Option Care Health has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Humana offers a yield of 1.39% to investors and pays a quarterly dividend of $0.89 per share. Option Care Health pays -- of its earnings as a dividend. Humana pays out 17.32% of its earnings as a dividend. Humana's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Option Care Health quarterly revenues are $1.3B, which are smaller than Humana quarterly revenues of $29.4B. Option Care Health's net income of $53.9M is lower than Humana's net income of $480M. Notably, Option Care Health's price-to-earnings ratio is 19.20x while Humana's PE ratio is 22.64x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Option Care Health is 0.84x versus 0.27x for Humana. Usually stocks with elevated PS ratios are considered overvalued.

OptimizeRx has a net margin of 4.21% compared to Option Care Health's net margin of -42.82%. Option Care Health's return on equity of 14.65% beat OptimizeRx's return on equity of -20.12%.

Option Care Health has a consensus price target of --, signalling upside risk potential of 31.78%. On the other hand OptimizeRx has an analysts' consensus of $9.79 which suggests that it could grow by 92.25%. Given that OptimizeRx has higher upside potential than Option Care Health, analysts believe OptimizeRx is more attractive than Option Care Health.

Option Care Health has a beta of 1.332, which suggesting that the stock is 33.16% more volatile than S&P 500. In comparison OptimizeRx has a beta of 1.341, suggesting its more volatile than the S&P 500 by 34.097%.

Option Care Health has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. OptimizeRx offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Option Care Health pays -- of its earnings as a dividend. OptimizeRx pays out -- of its earnings as a dividend.

Option Care Health quarterly revenues are $1.3B, which are larger than OptimizeRx quarterly revenues of $21.3M. Option Care Health's net income of $53.9M is higher than OptimizeRx's net income of -$9.1M. Notably, Option Care Health's price-to-earnings ratio is 19.20x while OptimizeRx's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Option Care Health is 0.84x versus 1.05x for OptimizeRx. Usually stocks with elevated PS ratios are considered overvalued.

Regional Health Properties has a net margin of 4.21% compared to Option Care Health's net margin of -23.24%. Option Care Health's return on equity of 14.65% beat Regional Health Properties's return on equity of -489.72%.

Option Care Health has a consensus price target of --, signalling upside risk potential of 31.78%. On the other hand Regional Health Properties has an analysts' consensus of -- which suggests that it could grow by 319.36%. Given that Regional Health Properties has higher upside potential than Option Care Health, analysts believe Regional Health Properties is more attractive than Option Care Health.

Option Care Health has a beta of 1.332, which suggesting that the stock is 33.16% more volatile than S&P 500. In comparison Regional Health Properties has a beta of 0.916, suggesting its less volatile than the S&P 500 by 8.446%.

Option Care Health has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Regional Health Properties offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Option Care Health pays -- of its earnings as a dividend. Regional Health Properties pays out -- of its earnings as a dividend.

Option Care Health quarterly revenues are $1.3B, which are larger than Regional Health Properties quarterly revenues of $4.2M. Option Care Health's net income of $53.9M is higher than Regional Health Properties's net income of -$982K. Notably, Option Care Health's price-to-earnings ratio is 19.20x while Regional Health Properties's PE ratio is 0.13x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Option Care Health is 0.84x versus 0.17x for Regional Health Properties. Usually stocks with elevated PS ratios are considered overvalued.